R
Rakesh K. Jain
Researcher at Harvard University
Publications - 1528
Citations - 198912
Rakesh K. Jain is an academic researcher from Harvard University. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 200, co-authored 1467 publications receiving 177727 citations. Previous affiliations of Rakesh K. Jain include Government Medical College, Thiruvananthapuram & University of Oslo.
Papers
More filters
Journal ArticleDOI
Non-reducing terminal linkage position determination in intact and permethylated synthetic oligosaccharides having a penultimate amino sugar: fast atom bombardment ionization, collisional-induced dissociation and tandem mass spectrometry.
Roger A. Laine,Eunsun Yoon,Thomas J. Mahier,Saeed A. Abbas,Brock W. de Lappe,Rakesh K. Jain,Khushi L. Matta +6 more
TL;DR: It is observed that protonated, ammoniated and lithiated molecular ions all produce linkage-specific daughter ion spectra in these two sets of oligosaccharides, and permethylated derivatives of this set of compounds give more useful product ions, including a 3-linkage specific ion.
Journal ArticleDOI
αPlGF: A New Kid on the Antiangiogenesis Block
Rakesh K. Jain,Lei Xu +1 more
TL;DR: Fischer et al. as mentioned in this paper showed that a monoclonal antibody against placental growth factor (PlGF), a member of the VEGF family, has such potential in mice.
Journal ArticleDOI
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.
Clemens Grassberger,Theodore S. Hong,Tai Hato,Beow Y. Yeap,Jennifer Y. Wo,Mark Tracy,Thomas Bortfeld,John A. Wolfgang,Christine E. Eyler,Lipika Goyal,Jeffrey W. Clark,Christopher H. Crane,Eugene J. Koay,Mark Cobbold,Thomas F. DeLaney,Rakesh K. Jain,Andrew X. Zhu,Dan G. Duda +17 more
TL;DR: Antitumor immunity may depend on maintenance of a sufficiently high number of activated CTLs during hypofractionated proton therapy in HCC patients and CD4+ CD25+ T cells and CD3- CD56+ natural killer cells prior to treatment in ICC patients.
Journal ArticleDOI
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
Ian A. Cook,Aimee M. Hunter,William S. Gilmer,Dan V. Iosifescu,Sidney Zisook,Karl Burgoyne,Robert H Howland,Madhukar H. Trivedi,Rakesh K. Jain,Scott D. Greenwald,Andrew F. Leuchter +10 more
TL;DR: The ATR index predicted remission at 13 weeks as well as the speed of achieving sustained remission with antidepressant monotherapy, suggesting that the ATR biomarker may predict stable longer-term outcomes.
Journal ArticleDOI
A transient parabiosis skin transplantation model in mice
TL;DR: This protocol describes the use of parabiosis for efficient transplantation of skin from a transgenic to a wild-type mouse to study the role of stromal cells in a spontaneous model of distant cancer dissemination (metastasis).